Partners for Patients NGO received approval from the European Parliament to hold a series of events focusing on the hurdles and opportunities for participating in and conducting clinical trials in Europe.

The under representation and lack of diversity in clinical trials of both patients and investigators is a key issue that healthcare and pharmaceutical industries must address to reduce the health disparities in society.

Aim: To increase the number of good clinical trials, offer patient access, and keep innovation in the European Union. High quality in clinical trials necessitates embracing diversity.